Kylin Therapeutics
West Lafayette
About Kylin Therapeutics
Kylin Therapeutics, a biotechnology company, employs an RNA nanoparticle technology platform called “pRNA“ to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. The platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome many challenges in the development of RNA-based therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Seed (Nov 2009)
- Website: kylintherapeutics.com
- Phone: 765.269.8030
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/kylin-therapeutics-2067118 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.